-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2017 to 2021.
- Aridis Pharmaceuticals, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2023 was 0 USD/shares.
- Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2021 was -3.77 USD/shares, a 54.5% decline from 2020.
- Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2020 was -2.44 USD/shares.
- Aridis Pharmaceuticals, Inc. annual Earnings Per Share, Diluted for 2018 was -7.45 USD/shares, a 95.5% increase from 2017.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)